Trial intelligence / Profile preview

Effects of oxygen treatment on mechanisms involved in ischemia-reperfusion injury

2014-002282-30Phase 4Completed

Sponsor
Region Östergötland
Start
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of atorvastatin in myocardial ischemia-reperfusion injury, sponsored by Region Östergötland. Primary endpoint: Plasma biomarkers of matrix remodeling, apoptosis, inflammation, and oxidative stress. Started Jun 2014; status: completed.

02

Drugs

atorvastatin
03

Conditions

myocardial ischemia-reperfusion injury

Beyond the preview

Go deeper on 2014-002282-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002282-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call